Ms. Meng Shasha, born in 1981, is a Chinese national with no permanent residency abroad and holds a Ph.D. in Science from the School of Public Health at Harvard University. Prior to joining MicroPort®, she served as research manager at the Memorial Sloan-Kettering Cancer Center in New York from June 2006 to August 2010, and served as senior consultant and project manager at Strategy& from October 2015 to August 2020. She has been CEO assistant and headquarters office director in MicroPort® since September 2020, and Ms. Meng has been director of Endovastec™ since November 2023.